Annual ROE
256.97%
+793.53%+147.89%
31 December 2023
Summary:
NRx Pharmaceuticals annual return on equity is currently 256.97%, with the most recent change of +793.53% (+147.89%) on 31 December 2023. During the last 3 years, it has risen by +138.68% (+117.24%). NRXPW annual ROE is now at all-time high.NRXPW ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
127.35%
-65.76%-34.05%
30 September 2024
Summary:
NRx Pharmaceuticals quarterly return on equity is currently 127.35%, with the most recent change of -65.76% (-34.05%) on 30 September 2024. Over the past year, it has increased by +29.84% (+30.60%). NRXPW quarterly ROE is now -99.97% below its all-time high of 495.70 thousand%, reached on 31 December 2021.NRXPW Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NRXPW ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +147.9% | +30.6% |
| 3 y3 years | +117.2% | -94.2% |
| 5 y5 years | - | +1405.3% |
NRXPW ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +147.9% | -100.0% | +30.6% |
| 5 y | 5 years | at high | +147.9% | -100.0% | +105.0% |
| alltime | all time | at high | +147.9% | -100.0% | +105.0% |
NRx Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 127.35%(-34.1%) |
| June 2024 | - | 193.11%(+25.6%) |
| Mar 2024 | - | 153.75%(+32.8%) |
| Dec 2023 | 256.97%(-147.9%) | 115.81%(+18.8%) |
| Sept 2023 | - | 97.51%(-99.9%) |
| Dec 2022 | -536.56%(+20.0%) | - |
| June 2022 | - | 94.01 K%(-49.3%) |
| Mar 2022 | - | 185.31 K%(-62.6%) |
| Dec 2021 | -447.29% | 495.70 K%(>+9900.0%) |
| Sept 2021 | - | 2206.30%(+174.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2021 | - | 802.87%(-131.8%) |
| Mar 2021 | - | -2525.38%(+876.7%) |
| Dec 2020 | 118.29%(+1347.9%) | -258.57%(+67.0%) |
| Sept 2020 | - | -154.84%(-1704.6%) |
| June 2020 | - | 9.65%(-8.3%) |
| Mar 2020 | - | 10.52%(+28.8%) |
| Dec 2019 | 8.17% | 8.17%(-3.4%) |
| Sept 2019 | - | 8.46%(+16.2%) |
| June 2019 | - | 7.28%(+93.6%) |
| Mar 2019 | - | 3.76% |
FAQ
- What is NRx Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals annual ROE year-on-year change?
- What is NRx Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals quarterly ROE year-on-year change?
What is NRx Pharmaceuticals annual return on equity?
The current annual ROE of NRXPW is 256.97%
What is the all time high annual ROE for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high annual return on equity is 256.97%
What is NRx Pharmaceuticals annual ROE year-on-year change?
Over the past year, NRXPW annual return on equity has changed by +793.53% (+147.89%)
What is NRx Pharmaceuticals quarterly return on equity?
The current quarterly ROE of NRXPW is 127.35%
What is the all time high quarterly ROE for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high quarterly return on equity is 495.70 K%
What is NRx Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, NRXPW quarterly return on equity has changed by +29.84% (+30.60%)